{
  "table_name": "PURITY_PLOIDY_ALL_SAMPLES_FILTERED",
  "table_fullname": "PANCANCER_ATLAS_1.PANCANCER_ATLAS_FILTERED.PURITY_PLOIDY_ALL_SAMPLES_FILTERED",
  "column_names": [
    "Pureté",
    "Étude",
    "Cancer_DNA_fraction",
    "CallStatus",
    "SampleBarcode",
    "ParticipantBarcode",
    "SampleTypeLetterCode",
    "Subclonal_genome_fraction",
    "Genome_doublings",
    "Ploidy",
    "Solution",
    "Type_d’échantillon",
    "AliquotBarcode",
    "Coverage_for_80_power"
  ],
  "column_types": [
    "FLOAT",
    "TEXT",
    "FLOAT",
    "TEXT",
    "TEXT",
    "TEXT",
    "TEXT",
    "FLOAT",
    "FLOAT",
    "FLOAT",
    "TEXT",
    "TEXT",
    "TEXT",
    "FLOAT"
  ],
  "description": [
    "Estimations de pureté ; valeurs entre 0 et 1 représentant la fraction de cellules cancéreuses dans un échantillon de tumeur solide",
    "Abréviation d'étude TCGA, par exemple LAML. Liste complète disponible à https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations",
    "Fractions d'ADN cancéreux ; plus d'informations disponibles à https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383288/",
    "Soit 'called' ou NULL indiquant si les données ont été analysées ou non",
    "Code à barres de l'échantillon de biospecimen, par exemple TCGA-13-1489-02A",
    "Identifiant de code à barres TCGA pour le participant à l'étude, par exemple TCGA-02-0001",
    "Code lettre du type d'échantillon en utilisant les normes TCGA, par exemple TPN, EBV. Liste complète disponible à https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/sample-type-codes",
    "Fractions de génome sous-clonales ; plus d'informations disponibles à https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383288/",
    "Nombre de duplications du génome entier",
    "Valeur basée sur la teneur en ADN de la population de cellules tumorales par rapport à la diploïdie normale",
    "Calculs/solutions 'nouveaux' ou 'anciens'",
    "Il existe 10 types d'échantillons : Sang Dérivé Normal, Tumeur Solide Primaire, Tissu Solide Normal, Tumeur Solide Récurrente, Métastatique, Nouveau Primaire Supplémentaire, Cancer Dérivé du Sang Primaire - Sang Péritphérique, Cellule Buccale Normale, Métastatique Supplémentaire, Moelle Osseuse Normale",
    "Code à barres de l'aliquote TCGA, par exemple TCGA-12-1089-01A-01D-0517-28",
    "Couverture moyenne nécessaire pour obtenir 80 % de puissance dans 80 % de la fraction du génome"
  ],
  "sample_rows": [
    {
      "AliquotBarcode": "TCGA-AB-2879-03A-01D-0756-21",
      "ParticipantBarcode": "TCGA-AB-2879",
      "SampleBarcode": "TCGA-AB-2879-03A",
      "CallStatus": "called",
      "Pureté": 0.25,
      "Ploidy": 2.0,
      "Genome_doublings": 0.0,
      "Coverage_for_80_power": 43.0,
      "Cancer_DNA_fraction": 0.25,
      "Subclonal_genome_fraction": 0.0,
      "Solution": "new",
      "Étude": "LAML",
      "SampleTypeLetterCode": "TB",
      "Type_d’échantillon": "Primary Blood Derived Cancer - Peripheral Blood"
    },
    {
      "AliquotBarcode": "TCGA-ZC-AAAH-01A-11D-A427-01",
      "ParticipantBarcode": "TCGA-ZC-AAAH",
      "SampleBarcode": "TCGA-ZC-AAAH-01A",
      "CallStatus": "called",
      "Pureté": 0.25,
      "Ploidy": 2.0,
      "Genome_doublings": 0.0,
      "Coverage_for_80_power": 43.0,
      "Cancer_DNA_fraction": 0.25,
      "Subclonal_genome_fraction": 0.09,
      "Solution": "new",
      "Étude": "THYM",
      "SampleTypeLetterCode": "TP",
      "Type_d’échantillon": "Primary solid Tumor"
    },
    {
      "AliquotBarcode": "TCGA-44-3396-01A-01D-1204-01",
      "ParticipantBarcode": "TCGA-44-3396",
      "SampleBarcode": "TCGA-44-3396-01A",
      "CallStatus": "called",
      "Pureté": 0.24,
      "Ploidy": 2.13,
      "Genome_doublings": 0.0,
      "Coverage_for_80_power": 45.0,
      "Cancer_DNA_fraction": 0.25,
      "Subclonal_genome_fraction": 0.16,
      "Solution": "new",
      "Étude": "LUAD",
      "SampleTypeLetterCode": "TP",
      "Type_d’échantillon": "Primary solid Tumor"
    },
    {
      "AliquotBarcode": "TCGA-2K-A9WE-01A-11D-A381-01",
      "ParticipantBarcode": "TCGA-2K-A9WE",
      "SampleBarcode": "TCGA-2K-A9WE-01A",
      "CallStatus": "called",
      "Pureté": 0.22,
      "Ploidy": 2.38,
      "Genome_doublings": 0.0,
      "Coverage_for_80_power": 52.0,
      "Cancer_DNA_fraction": 0.25,
      "Subclonal_genome_fraction": 0.11,
      "Solution": "new",
      "Étude": "KIRP",
      "SampleTypeLetterCode": "TP",
      "Type_d’échantillon": "Primary solid Tumor"
    },
    {
      "AliquotBarcode": "TCGA-49-AAQV-01A-11D-A396-01",
      "ParticipantBarcode": "TCGA-49-AAQV",
      "SampleBarcode": "TCGA-49-AAQV-01A",
      "CallStatus": "called",
      "Pureté": 0.25,
      "Ploidy": 1.94,
      "Genome_doublings": 0.0,
      "Coverage_for_80_power": 41.0,
      "Cancer_DNA_fraction": 0.25,
      "Subclonal_genome_fraction": 0.43,
      "Solution": "new",
      "Étude": "LUAD",
      "SampleTypeLetterCode": "TP",
      "Type_d’échantillon": "Primary solid Tumor"
    }
  ]
}